Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/25489
Title: Role of the ubiquitin–proteasome system in brain ischemia: Friend or foe?
Authors: Caldeira, Margarida V. 
Salazar, Ivan L. 
Cursio, Michele 
Canzoniero, Lorella M. T. 
Duarte, Carlos B. 
Keywords: Ubiquitin–proteasome system; Brain ischemia; Excitotoxicity; Proteasome inhibitors
Issue Date: 2014
Publisher: Elsevier Ltd.
Serial title, monograph or event: Progress in Neurobiology
Volume: 112
Abstract: The ubiquitin–proteasome system (UPS) is a catalytic machinery that targets numerous cellular proteins for degradation, thus being essential to control a wide range of basic cellular processes and cell survival. Degradation of intracellular proteins via the UPS is a tightly regulated process initiated by tagging a target protein with a specific ubiquitin chain. Neurons are particularly vulnerable to any change in protein composition, and therefore the UPS is a key regulator of neuronal physiology. Alterations in UPS activity may induce pathological responses, ultimately leading to neuronal cell death. Brain ischemia triggers a complex series of biochemical and molecular mechanisms, such as an inflammatory response, an exacerbated production of misfolded and oxidized proteins, due to oxidative stress, and the breakdown of cellular integrity mainly mediated by excitotoxic glutamatergic signaling. Brain ischemia also damages protein degradation pathways which, together with the overproduction of damaged proteins and consequent upregulation of ubiquitin-conjugated proteins, contribute to the accumulation of ubiquitincontaining proteinaceous deposits. Despite recent advances, the factors leading to deposition of such aggregates after cerebral ischemic injury remain poorly understood. This review discusses the current knowledge on the role of the UPS in brain function and the molecular mechanisms contributing to UPS dysfunction in brain ischemia with consequent accumulation of ubiquitin-containing proteins. Chemical inhibitors of the proteasome and small molecule inhibitors of deubiquitinating enzymes, which promote the degradation of proteins by the proteasome, were both shown to provide neuroprotection in brain ischemia, and this apparent contradiction is also discussed in this review.
URI: http://hdl.handle.net/10316/25489
DOI: 10.1016/j.pneurobio.2013.10.003
Rights: openAccess
Appears in Collections:FCTUC Ciências da Vida - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
1-s2.0-S0301008213001032-main.pdf2.16 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

70
checked on Feb 18, 2020

WEB OF SCIENCETM
Citations

65
checked on Feb 18, 2020

Page view(s)

210
checked on Aug 13, 2020

Download(s)

410
checked on Aug 13, 2020

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.